Update: 24.01.2023
Last week: 2 week 2023 (09.01.2023 - 15.01.2023)
Last full month: December 2022
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 125 448 | 4.1% | 2.8% | -0.1 | 33 904 780 | 6.7% | 3.5% | 0.1 | 6.7% |
| MoM | 881 320 | 45.7% | 3.1% | -0.2 | 211 916 362 | 53.0% | 3.4% | 0 | 53.3% |
| YTD | 245 954 | -60.0% | 2.8% | -3.8 | 65 669 710 | -43.4% | 3.5% | -2.9 | -6.1% |
| MAT | 9 477 346 | -30.5% | 4.6% | -1.9 | 1 969 877 248 | -16.6% | 4.6% | -1.3 | -2.4% |
| DEXALGIN | |||||||||
| WoW | 20 014 | 10.2% | 0.4% | -0.1 | 10 482 157 | 8.4% | 1.3% | -0.2 | 24.5% |
| MoM | 86 814 | 27.7% | 0.3% | 0 | 42 243 433 | 24.6% | 1.1% | 0 | 29.0% |
| YTD | 38 182 | -56.1% | 0.4% | -0.5 | 20 154 204 | -40.6% | 1.4% | -1.1 | -5.2% |
| MAT | 1 536 819 | -17.6% | 0.6% | -0.1 | 672 943 718 | -5.5% | 1.7% | -0.3 | -0.4% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 53 997 | 33.9% | 39.7% | 0.3 | 36 243 073 | 46.4% | 52.2% | 3.1 | 32.8% |
| MoM | 241 465 | 0.3% | 41.0% | -0.3 | 141 226 638 | 7.8% | 48.9% | 0.6 | 1.0% |
| YTD | 94 313 | -54.1% | 39.6% | -22.3 | 60 995 339 | -38.1% | 50.9% | -17.9 | -28.2% |
| MAT | 4 172 998 | -21.5% | 52.3% | -13.5 | 2 171 038 015 | -11.3% | 58.2% | -12.2 | -1.2% |
| ESPUMISAN BABY | |||||||||
| WoW | 19 676 | 4.1% | 27.3% | -4.1 | 15 366 952 | 8.0% | 43.6% | -4 | 19.6% |
| MoM | 101 055 | -2.2% | 31.5% | -2.3 | 71 889 362 | 3.5% | 46.8% | -0.7 | 5.1% |
| YTD | 38 572 | -34.7% | 29.2% | -10.3 | 29 592 530 | -15.5% | 45.4% | -8.7 | -11.5% |
| MAT | 1 405 653 | -15.3% | 36.6% | -4.7 | 900 159 231 | -7.4% | 50.0% | -6 | -4.4% |
| FASTUM | |||||||||
| WoW | 16 410 | 16.6% | 1.0% | -0.1 | 10 216 749 | 19.9% | 2.7% | -0.1 | 26.2% |
| MoM | 67 210 | -6.8% | 0.8% | -0.1 | 38 269 832 | -6.6% | 2.2% | -0.2 | 2.4% |
| YTD | 30 488 | -41.7% | 1.0% | -0.6 | 18 740 611 | -24.4% | 2.7% | -0.8 | -8.6% |
| MAT | 1 018 796 | -26.4% | 1.1% | -0.4 | 540 310 043 | -15.8% | 2.5% | -0.7 | -0.4% |
| IODOMARIN | |||||||||
| WoW | 60 106 | 42.7% | 20.5% | 0.1 | 11 040 409 | 41.4% | 7.8% | 0.4 | 42.0% |
| MoM | 292 263 | -2.5% | 21.9% | -1.3 | 53 688 884 | -3.2% | 8.6% | -1.2 | 3.2% |
| YTD | 102 236 | -19.2% | 20.5% | -2.1 | 18 847 736 | -18.5% | 7.7% | -2.4 | -11.0% |
| MAT | 3 269 142 | 2.1% | 20.5% | -0.3 | 635 726 984 | 6.5% | 9.0% | -0.4 | 3.5% |
| LIOTON | |||||||||
| WoW | 12 579 | 20.1% | 1.4% | 0 | 15 319 148 | 23.5% | 3.5% | -0.2 | 22.5% |
| MoM | 67 343 | -6.9% | 1.6% | -0.2 | 79 801 344 | -4.4% | 4.2% | -0.1 | 2.6% |
| YTD | 23 052 | -54.5% | 1.4% | -1.2 | 27 719 281 | -37.7% | 3.6% | -2.1 | -15.4% |
| MAT | 1 223 933 | -27.8% | 2.2% | -0.6 | 1 290 604 563 | -8.6% | 4.6% | -1.1 | -8.0% |
| MEZYM | |||||||||
| WoW | 232 758 | 3.4% | 19.2% | -1.9 | 36 163 346 | 6.0% | 13.1% | -1.4 | 13.9% |
| MoM | 1 051 039 | 14.1% | 18.6% | 0.2 | 155 837 829 | 14.1% | 12.7% | -0.2 | 12.8% |
| YTD | 457 849 | -51.1% | 20.1% | -12.3 | 70 266 215 | -46.7% | 13.8% | -10.4 | -21.1% |
| MAT | 16 872 576 | -19.5% | 24.9% | -4.3 | 2 582 565 880 | -12.2% | 17.7% | -4.2 | -5.4% |
| MIG 400 | |||||||||
| WoW | 112 930 | 11.4% | 2.2% | -0.3 | 14 817 728 | 14.2% | 1.9% | -0.1 | 24.5% |
| MoM | 640 170 | 14.7% | 2.4% | -0.3 | 78 597 858 | 16.9% | 2.0% | -0.1 | 29.0% |
| YTD | 214 312 | -36.4% | 2.3% | -1.2 | 27 790 844 | -28.2% | 2.0% | -1 | -5.2% |
| MAT | 8 273 722 | -17.2% | 3.2% | -0.6 | 983 304 993 | -12.9% | 2.4% | -0.7 | -0.4% |
| PROSTAMOL | |||||||||
| WoW | 23 303 | 42.7% | 14.5% | 1 | 35 615 047 | 51.8% | 16.6% | 1.6 | 33.4% |
| MoM | 102 828 | 1.0% | 13.4% | -0.7 | 143 857 913 | 2.0% | 14.4% | -0.6 | 6.2% |
| YTD | 39 631 | -47.2% | 14.1% | -9.8 | 59 075 766 | -40.1% | 16.0% | -9.8 | -10.7% |
| MAT | 1 511 113 | -29.3% | 17.8% | -6.8 | 2 125 257 728 | -21.4% | 19.0% | -7.7 | -2.3% |
| RESPERO MYRTOL | |||||||||
| WoW | 25 387 | 14.7% | 7.4% | -0.2 | 14 353 033 | 16.2% | 8.6% | -0.1 | 17.4% |
| MoM | 164 285 | 61.0% | 8.2% | 1.3 | 85 489 336 | 66.1% | 9.0% | 1.5 | 36.2% |
| YTD | 47 523 | -20.8% | 7.5% | -2 | 26 701 301 | 1.6% | 8.7% | -0.4 | 0.1% |
| MAT | 1 289 004 | 61.3% | 8.3% | 2.9 | 623 980 947 | 69.8% | 8.5% | 2.8 | 5.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 245 954 | -60.0% | 2.8% | -3.8 | 65 669 710 | -43.4% | 3.5% | -2.9 | -6.1% |
| DEXALGIN | 38 182 | -56.1% | 0.4% | -0.5 | 20 154 204 | -40.6% | 1.4% | -1.1 | -5.2% |
| ESPUMISAN (ADULTS) | 94 313 | -54.1% | 39.6% | -22.3 | 60 995 339 | -38.1% | 50.9% | -17.9 | -28.2% |
| ESPUMISAN BABY | 38 572 | -34.7% | 29.2% | -10.3 | 29 592 530 | -15.5% | 45.4% | -8.7 | -11.5% |
| FASTUM | 30 488 | -41.7% | 1.0% | -0.6 | 18 740 611 | -24.4% | 2.7% | -0.8 | -8.6% |
| IODOMARIN | 102 236 | -19.2% | 20.5% | -2.1 | 18 847 736 | -18.5% | 7.7% | -2.4 | -11.0% |
| LIOTON | 23 052 | -54.5% | 1.4% | -1.2 | 27 719 281 | -37.7% | 3.6% | -2.1 | -15.4% |
| MEZYM | 457 849 | -51.1% | 20.1% | -12.3 | 70 266 215 | -46.7% | 13.8% | -10.4 | -21.1% |
| MIG 400 | 214 312 | -36.4% | 2.3% | -1.2 | 27 790 844 | -28.2% | 2.0% | -1 | -5.2% |
| PROSTAMOL | 39 631 | -47.2% | 14.1% | -9.8 | 59 075 766 | -40.1% | 16.0% | -9.8 | -10.7% |
| RESPERO MYRTOL | 47 523 | -20.8% | 7.5% | -2 | 26 701 301 | 1.6% | 8.7% | -0.4 | 0.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 9 477 346 | -30.5% | 4.6% | -1.9 | 1 969 877 248 | -16.6% | 4.6% | -1.3 | -2.4% |
| DEXALGIN | 1 536 819 | -17.6% | 0.6% | -0.1 | 672 943 718 | -5.5% | 1.7% | -0.3 | -0.4% |
| ESPUMISAN (ADULTS) | 4 172 998 | -21.5% | 52.3% | -13.5 | 2 171 038 015 | -11.3% | 58.2% | -12.2 | -1.2% |
| ESPUMISAN BABY | 1 405 653 | -15.3% | 36.6% | -4.7 | 900 159 231 | -7.4% | 50.0% | -6 | -4.4% |
| FASTUM | 1 018 796 | -26.4% | 1.1% | -0.4 | 540 310 043 | -15.8% | 2.5% | -0.7 | -0.4% |
| IODOMARIN | 3 269 142 | 2.1% | 20.5% | -0.3 | 635 726 984 | 6.5% | 9.0% | -0.4 | 3.5% |
| LIOTON | 1 223 933 | -27.8% | 2.2% | -0.6 | 1 290 604 563 | -8.6% | 4.6% | -1.1 | -8.0% |
| MEZYM | 16 872 576 | -19.5% | 24.9% | -4.3 | 2 582 565 880 | -12.2% | 17.7% | -4.2 | -5.4% |
| MIG 400 | 8 273 722 | -17.2% | 3.2% | -0.6 | 983 304 993 | -12.9% | 2.4% | -0.7 | -0.4% |
| PROSTAMOL | 1 511 113 | -29.3% | 17.8% | -6.8 | 2 125 257 728 | -21.4% | 19.0% | -7.7 | -2.3% |
| RESPERO MYRTOL | 1 289 004 | 61.3% | 8.3% | 2.9 | 623 980 947 | 69.8% | 8.5% | 2.8 | 5.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 125 448 | 4.1% | 2.8% | -0.1 | 33 904 780 | 6.7% | 3.5% | 0.1 | 6.7% |
| DEXALGIN | 20 014 | 10.2% | 0.4% | -0.1 | 10 482 157 | 8.4% | 1.3% | -0.2 | 24.5% |
| ESPUMISAN (ADULTS) | 53 997 | 33.9% | 39.7% | 0.3 | 36 243 073 | 46.4% | 52.2% | 3.1 | 32.8% |
| ESPUMISAN BABY | 19 676 | 4.1% | 27.3% | -4.1 | 15 366 952 | 8.0% | 43.6% | -4 | 19.6% |
| FASTUM | 16 410 | 16.6% | 1.0% | -0.1 | 10 216 749 | 19.9% | 2.7% | -0.1 | 26.2% |
| IODOMARIN | 60 106 | 42.7% | 20.5% | 0.1 | 11 040 409 | 41.4% | 7.8% | 0.4 | 42.0% |
| LIOTON | 12 579 | 20.1% | 1.4% | 0 | 15 319 148 | 23.5% | 3.5% | -0.2 | 22.5% |
| MEZYM | 232 758 | 3.4% | 19.2% | -1.9 | 36 163 346 | 6.0% | 13.1% | -1.4 | 13.9% |
| MIG 400 | 112 930 | 11.4% | 2.2% | -0.3 | 14 817 728 | 14.2% | 1.9% | -0.1 | 24.5% |
| PROSTAMOL | 23 303 | 42.7% | 14.5% | 1 | 35 615 047 | 51.8% | 16.6% | 1.6 | 33.4% |
| RESPERO MYRTOL | 25 387 | 14.7% | 7.4% | -0.2 | 14 353 033 | 16.2% | 8.6% | -0.1 | 17.4% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 881 320 | 45.7% | 3.1% | -0.2 | 211 916 362 | 53.0% | 3.4% | 0 | 53.3% |
| DEXALGIN | 86 814 | 27.7% | 0.3% | 0 | 42 243 433 | 24.6% | 1.1% | 0 | 29.0% |
| ESPUMISAN (ADULTS) | 241 465 | 0.3% | 41.0% | -0.3 | 141 226 638 | 7.8% | 48.9% | 0.6 | 1.0% |
| ESPUMISAN BABY | 101 055 | -2.2% | 31.5% | -2.3 | 71 889 362 | 3.5% | 46.8% | -0.7 | 5.1% |
| FASTUM | 67 210 | -6.8% | 0.8% | -0.1 | 38 269 832 | -6.6% | 2.2% | -0.2 | 2.4% |
| IODOMARIN | 292 263 | -2.5% | 21.9% | -1.3 | 53 688 884 | -3.2% | 8.6% | -1.2 | 3.2% |
| LIOTON | 67 343 | -6.9% | 1.6% | -0.2 | 79 801 344 | -4.4% | 4.2% | -0.1 | 2.6% |
| MEZYM | 1 051 039 | 14.1% | 18.6% | 0.2 | 155 837 829 | 14.1% | 12.7% | -0.2 | 12.8% |
| MIG 400 | 640 170 | 14.7% | 2.4% | -0.3 | 78 597 858 | 16.9% | 2.0% | -0.1 | 29.0% |
| PROSTAMOL | 102 828 | 1.0% | 13.4% | -0.7 | 143 857 913 | 2.0% | 14.4% | -0.6 | 6.2% |
| RESPERO MYRTOL | 164 285 | 61.0% | 8.2% | 1.3 | 85 489 336 | 66.1% | 9.0% | 1.5 | 36.2% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"
## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"
## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"
## [1] "ESPUMISAN (ADULTS)"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"
## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"
## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"
## [1] "ESPUMISAN BABY"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"
## [1] "FASTUM"
## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"
## [1] "LIOTON"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"
## [1] "MEZYM"
## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS 20000 IU #20"
## [1] "MEZYM FORTE COATED TABLETS #20"
## [1] "MEZYM FORTE COATED TABLETS #80"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"
## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS 10000 ED #20"
## [1] "DEXALGIN"
## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"
## [1] "MIG 400"
## [1] "MIG 400 COATED TABLETS 400 MG #10"
## [1] "MIG 400 COATED TABLETS 400 MG #20"
## [1] "PROSTAMOL"
## [1] "PROSTAMOL UNO CAPS 320 MG #30"
## [1] "PROSTAMOL UNO CAPS 320 MG #60"
## [1] "PROSTAMOL UNO CAPS 320 MG #90"
## [1] "IODOMARIN"
## [1] "IODOMARIN 100 TABS 100 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #50"
## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"
## [1] "RESPERO MYRTOL"
## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"
## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs